纳米与耐药结核病:采取肺部路线
Deepika Sharma1, Pooja1, Sunita Nirban1
1Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh, 123031, Haryana, India.
AAPS PharmSciTech
|December 4, 2023
概括
结核病 (TB) 治疗面临着耐药性和不有效的药物输送的挑战. 纳米技术为向肺部药物输送提供了一个有前途的解决方案,以对抗多药耐药 (MDR) 和广泛耐药 (XDR) 结核病.
科学领域:
- 医学微生物学 医学微生物学
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 仍然是全球领先的传染病杀手,每年有数百万人死亡.
- 治疗不坚持导致多药耐药 (MDR) 和广泛耐药 (XDR) 结核病的增加.
- 传统的治疗方法难以消除肺气泡中的结核病储存库,并面临抗药性挑战.
研究的目的:
- 审查使用纳米技术治疗结核病的肺药物输送系统的意义和最近的进展.
- 探索纳米技术在克服结核病耐药性和改善患者服药性方面的潜力.
- 讨论结核病的流行,纳米医学开发的必要性,纳米载体的好处,安全性和临床应用.
主要方法:
- 文献综述侧重于纳米技术在结核病肺部药物输送中的应用.
- 对纳米载体的研究分析,以准肺部的结核病储存库.
- 检查使用纳米医学策略对抗MDR和XDR-TB的研究.
主要成果:
- 纳米技术为准确诊断和有效治疗结核病,包括MDR和XDR菌株提供了可行的策略.
- 通过纳米技术的肺部药物输送可以提高对肺结核储存库的治疗疗效.
- 纳米医学有可能改善患者的服从性,克服复发性结核病感染.
结论:
- 纳米技术在开发先进的肺药物输送系统方面具有显著的前景,以应对耐药结核病日益增长的威胁.
- 通过纳米载体向肺部的向输送可以改善治疗结果,并解决当前结核病治疗的局限性.
- 进一步的研究和临床研究对于充分实现纳米医学在结核病管理中的潜力至关重要.
相关概念视频
Pulmonary Tuberculosis II
242
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
242
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis V
181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis III
336
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
336


